In mice, blocking heart-to-brain signals improved healing after a heart attack, hinting at new targets for cardiac therapy.

Heart failure has historically been irreversible, but the outcome of a new study suggests that could someday change. At the University of Utah, scientists used a new gene therapy that was shown to ...

Aims Heart failure (HF) often coexists with chronic kidney disease (CKD), impacting prognosis. This study aims to evaluate ...

Maintaining a stable heartbeat is critical for survival. Your heart must constantly adapt its output to meet changing demands ...

Scientists have identified a key reason why more than half of people with chronic kidney disease eventually die from heart-related conditions. New evidence shows that damaged kidneys release a ...

Ifetroban significantly improved LVEF in DMD patients, showing a 5.4% improvement compared with propensity-matched natural history controls, with high-dose treatment yielding the most benefit. The ...

Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...

Heart attack symptoms in women can differ from the classic warning signs portrayed in men. Women may notice symptoms such as shortness of breath, nausea or overwhelming ...

Heart conditions seldom make their presence known with loud warnings or obvious signals. Often, it starts in a hushed ...

Emerging evidence suggests that "night owls" are more likely to have poor heart health and a higher risk of heart attack or stroke than "morning larks." Why is that?

Lower cardiac output has been tied to poorer cerebral blood flow (CBF) in the temporal lobes of older adults without heart failure, a finding that adds to a growing body of research linking heart ...